Quipt Home Medical Corp. reported a total revenue of $245.4 million for the fiscal year ending September 30, 2025, a slight decrease of 0.2% from $245.9 million in the previous year. The company attributed this decline primarily to challenges such as the discontinuation of the Medicare 75/25 blended rate, which had provided rate relief in certain areas, and the withdrawal of Medicare Advantage members. Despite these setbacks, Quipt's revenue for the three months ending September 30, 2025, increased by 11.4% to $68.3 million, largely due to contributions from recent acquisitions.
The company experienced a net loss of $10.7 million for the year, compared to a loss of $6.8 million in the prior year. This increase in losses was influenced by various factors, including the impact of the Change Healthcare cybersecurity incident, which hindered claims processing and cash flow. Operating expenses rose to $125.5 million, up from $122.5 million, driven by costs associated with acquisitions and increased operational activities. The company’s Adjusted EBITDA for the year was $55.9 million, down from $57.7 million in 2024.
Quipt has made significant strategic moves, including the acquisition of Mediserve Medical Equipment for $2.6 million and a 60% interest in Hart Medical Equipment for $17.4 million, both completed in 2025. These acquisitions are part of Quipt's strategy to expand its footprint in the durable medical equipment market, which now spans 27 states. The company reported serving approximately 346,000 patients in 2025, an increase from 314,000 in 2024, and completed 917,000 equipment setups or deliveries, up from 854,000 the previous year.
As of September 30, 2025, Quipt's total assets increased to $283.3 million from $247.2 million in 2024, while total liabilities rose to $171.2 million from $140.1 million. The company had approximately 1,600 employees, reflecting its growth and operational expansion. Looking ahead, Quipt aims to generate operating profit and positive cash flow while continuing to leverage its acquisitions to enhance revenue and operational efficiencies. The company is also preparing for a transition to private ownership following an announced acquisition agreement at $3.65 per share, expected to close in the first half of 2026.
About Quipt Home Medical Corp.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.